Datasheet | June 27, 2023

4Cell® Nutri-T Media

Source: Sartorius
4Cell® Nutri-T Media Feature

Cell-based immunotherapy is at the forefront of advanced cancer treatments. The most common cell-based immunotherapies to date are T-cell therapies. Cells being used for immunotherapy are commonly cultured in media supplemented with human serum. The use of serum introduces further variability into the process due to donor-to-donor variation, which leads to inconsistent cell growth and characteristics. Eliminating serum simplifies the process, lowers the regulatory risk, and reduces the associated logistical burden.

Nutri-T media eliminate this need for serum addition by substituting serum’s critical components with specific proteins, lipids, and other small molecules. Learn more about this xeno-free, serum-free media for the cultivation of lymphocytes.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online